retatrutide clinical trial phase retatrutide Availability & Timeline Will Reta Rewrite Obesity? -

This means a vial reconstituted for the 2mg phase (which provides 5 weekly doses from a 10mg vial) should be used within about 5 weeks, which aligns perfectly with the 4-week dose escalation schedule plus a small buffer

Men over 40 typically see: Faster initial scale movement (58 lbs in weeks 14 versus 25 lbs for women) More linear weekly loss patterns Less hormonal water retention masking results Stronger early appetite suppression response Women over 40 typically see: Slower initial scale loss but more dramatic body composition change relative to scale weight Greater week-to-week scale fluctuation due to cycle and hormonal factors Faster muscle and waist response when protein intake is adequate More pronounced GI side effects at the same per-kilogram dose The most important difference is in the metrics that matter

Limitations of the TRIUMPH-1 results The results of TRIUMPH-1 have only come through a press release, not the publication of a peer-reviewed journal

Markets are now watching pricing, insurance coverage, and patient adoption as the next determinants of how disruptive this shift from injections to pills could be